Attention AACR-NCI-EORTC Molecular Targets Conference Registrants - Activate Your Access

Login for full access:

Username and password are not your MyAACR account information

Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Conferences:

Availability:

Participation Type:

Presentations Access:

Presentation Access:

Topic Tracks*:

Organ Site Tracks*:

  • Sort by:
  • Browse by:
<< first | < prev page: of 5 records per page: next > | last >>
pages: 1 2 3 4 5 presentations: 1 to 25 of 102
Introduction: Why study environmental carcinogenesis?
Margaret L. Kripke
UT MD Anderson Cancer Center, Houston, TX, United States
from AACR Annual Meeting 2017 on April 1, 2017 10:15 AM-12:15 PM
Environmental carcinogenesis: Progress, challenges, and opportunities
John R. Bucher
National Institutes of Health, Research Triangle Park, NC, United States
from AACR Annual Meeting 2017 on April 1, 2017 10:15 AM-12:15 PM
Endocrine disruptors and reproductive cancers
Joan V Ruderman
Princeton University, Princeton, NJ, United States
from AACR Annual Meeting 2017 on April 1, 2017 10:15 AM-12:15 PM
Contribution of environmental exposures to childhood cancers
Philip J Landrigan
Icahn School of Medicine at Mt. Sinai, New York, NY, United States
from AACR Annual Meeting 2017 on April 1, 2017 10:15 AM-12:15 PM
Invited Speaker
Jason Carroll
Cancer Research UK Cambridge Research Inst., Cambridge, United Kingdom
from AACR Annual Meeting 2017 on April 2, 2017 7:00 AM-8:00 AM
ESR1 mutations activate and confer hormone resistance via distinct mechanisms.
Weiyi Toy
Mem. Sloan Kettering Cancer Ctr., New York, NY, United States
from AACR Annual Meeting 2017 on April 2, 2017 3:00 PM-5:00 PM
Estrogen receptor coactivator MED1 in breast tumorigenesis and therapeutic resistance
Xiaoting Zhang
University of Cincinnati, Cincinnati, OH, United States
from AACR Annual Meeting 2017 on April 2, 2017 3:00 PM-5:00 PM
ESR1 mutations confer novel metastatic functions in genome-edited breast cancer models
Zheqi Li
University of Pittsburgh, Pittsburgh, PA, United States
from AACR Annual Meeting 2017 on April 2, 2017 3:00 PM-5:00 PM
An epigenetic strategy to degrade the estrogen receptor in breast cancer
Cynthia A. Zahnow
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, United States
from AACR Annual Meeting 2017 on April 2, 2017 3:00 PM-5:00 PM
Extranuclear ERα-mTOR signaling rewires cancer cell metabolism during obesity-associated breast cancer
Zeynep Madak Erdogan
Univ. of Illinois at Urbana-Champaign, Urbana, IL, United States
from AACR Annual Meeting 2017 on April 2, 2017 3:00 PM-5:00 PM
LDLR knockdown reduces the growth of Her2 overexpressing breast cancer in mouse models of hyperlipidemia
Emily J Gallagher
Icahn School of Medicine at Mount Sinai, New York, NY, United States
from AACR Annual Meeting 2017 on April 2, 2017 3:00 PM-5:00 PM
Interaction between the estrogen receptor and fibroblast growth factor receptor pathways in non-small cell lung cancer
Laura P. Stabile
Univ. of Pittsburgh School of Medicine, Pittsburgh, PA, United States
from AACR Annual Meeting 2017 on April 2, 2017 3:00 PM-5:00 PM
Towards a national strategy to increase HPV vaccination
Electra D. Paskett
Ohio State Univ. Comp. Cancer Ctr., Columbus, OH, United States
from AACR Annual Meeting 2017 on April 3, 2017 10:30 AM-12:15 PM
Using implementation science to reduce urban and rural cancer disparities
Celette S. Skinner
UT Southwestern Medical Ctr., Dallas, TX, United States
from AACR Annual Meeting 2017 on April 3, 2017 10:30 AM-12:15 PM
Improving implementation of tobacco treatment guidelines in public dental care
Jamie S Ostroff
Mem. Sloan-Kettering Cancer Ctr., New York, NY, United States
from AACR Annual Meeting 2017 on April 3, 2017 10:30 AM-12:15 PM
Closing Remarks
Maria Elena Martinez
UCSD Moores Cancer Ctr., La Jolla, CA, United States
from AACR Annual Meeting 2017 on April 3, 2017 10:30 AM-12:15 PM
Invited Speaker
Myles A. Brown
Dana-Farber Cancer Inst., Boston, MA, United States
from AACR Annual Meeting 2017 on April 4, 2017 7:00 AM-8:00 AM
Stromal contributions of adipocytes to cancer
Philipp E. Scherer
UT Southwestern Medical Ctr., Dallas, TX, United States
from AACR Annual Meeting 2017 on April 4, 2017 10:30 AM-12:15 PM
The adipose-cancer link: From microenvironment to metabolomics
Cornelia M. Ulrich
Univ. of Utah Huntsman Cancer Inst., Salt Lake City, UT, United States
from AACR Annual Meeting 2017 on April 4, 2017 10:30 AM-12:15 PM
Wasting metabolism: Cancer cachexia and beyond
Stephan Herzig
German Cancer Research Center Heidelberg, Heidelberg, Germany
from AACR Annual Meeting 2017 on April 4, 2017 10:30 AM-12:15 PM
Molecular connections between obesity and cancer
Dipali Sharma
Johns Hopkins Kimmel Comp. Cancer Center, Baltimore, MD, United States
from AACR Annual Meeting 2017 on April 5, 2017 10:15 AM-12:00 PM
Inflammation and cancer: The role of exercise
Melinda L Irwin
Yale Univ. School of Public Health, New Haven, CT, United States
from AACR Annual Meeting 2017 on April 5, 2017 10:15 AM-12:00 PM
Inflammation and cancer: The role of caloric restriction and weight loss
Wendy Demark-Wahnefried
Univ. of Alabama Comp. Cancer Ctr., Birmingham, AL, United States
from AACR Annual Meeting 2017 on April 5, 2017 10:15 AM-12:00 PM
ESR1 coregulator binding inhibitor (ECBI): a novel agent for treating hormone therapy-resistant breast cancer
Ratna K. Vadlamudi
UT Health Science Center at San Antonio, San Antonio, TX, United States
from AACR Annual Meeting 2016 on April 17, 2016 4:15 PM-6:15 PM
Global transcription factor repression by the coactivator SRC-1 mediates disease progression in endocrine-resistant breast cancer
Damir Vareslija
Royal College of Surgeons in Ireland, Dublin, Ireland
from AACR Annual Meeting 2016 on April 17, 2016 4:15 PM-6:15 PM
<< first | < prev page: of 5 records per page: next > | last >>
pages: 1 2 3 4 5 presentations: 1 to 25 of 102